Response of carcinoma of unknown primary site affecting bone to thalidomide.
Department of Medical Oncology and Haematology, Whittingham Cancer Center, Norwalk Hospital, 24 Stevens Street, Norwalk, CT 06856, USA. richard.frank@norwalkhealth.org
Richard C
RC
Frank
Fred
F
Kaplan
Saraswathi
S
Nair
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary*; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy / Q000473:pathology*; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide; D003907:Dexamethasone